Hydrochlorothiazide: is it a wise choice?

Bibliography

• ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trail (ALLHAT). JAMA 2002;288:2981-97
   PubMed Web of Science ®Google Scholar
• SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64
   PubMed Web of Science ®Google Scholar
• Multiple Risk Factor Intervention Trail Research Group. Mortality after 10 ½ years for hypertensive participants in the multiple risk factor intervention trail. Circulation 1990;82:1616-28
   PubMed Web of Science ®Google Scholar
• Post-stroke antihypertensive treatment study. A preliminary result. PATS Collaborating Group. Chin Med J 1995;108:710-17
   PubMed Web of Science ®Google Scholar
• Beckett NS, Peters R, Fletcher AE, for the HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008;358:1887-98
   PubMed Web of Science ®Google Scholar
• PROGRESS Collaborative Group. Randomized trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet 2001;358:1033-41
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560-71
   PubMed Web of Science ®Google Scholar
• Kurtz TW. Chlorthalidone: don't call it “Thiazide-Like" anymore. Hypertension 2010;56:335-7
   PubMed Web of Science ®Google Scholar
• Leren P, Helgeland A. Oslo hypertension study. Drugs 1986;31:41-5
   PubMed Web of Science ®Google Scholar
• Ernst ME, Lund BC. Renewed interest in chlorthalidone: evidence from the veterans health administration. J Clin Hypertens 2010;12:927-34
   PubMed Web of Science ®Google Scholar
• Madkour H, Gadallah M, Riveline B, Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension. Am J Cardiol 1996;77:23B-5B
   PubMed Web of Science ®Google Scholar
• Carey PA, Sheridan DJ, de Cordoue A, Effect of indapamide on left ventricular hypertrophy in hypertension: a meta-analysis. Am J Cardiol 1996;77:17B-9B
   PubMed Web of Science ®Google Scholar
• Ernst ME, Neaton JD, Grimm RH Jr, for the Multiple Risk Factor Intervention Trial Research Group. Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the Multiple Risk Factor Intervention Trial. Hypertension 2011;58:1001-7
   PubMed Web of Science ®Google Scholar
• Jamerson K, Devereux R, Bakris GL, Efficacy and duration of benazepril plus amlodipine or hydrochlorthiazide on 24-h ambulatory systolic blood pressure control. Hypertension 2011;57:174-9
   PubMed Web of Science ®Google Scholar
• Ernst ME, Carter BL, Goerdt CJ, Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Hypertension 2006;47:352-8
   PubMed Web of Science ®Google Scholar
• Meserli FH, Makani H, Benjo H, Antihypertensive efficacy of HCTZ as evaluated by ABPM. A meta-analysis of randomized trials. J Am Coll Cardiol 2011;57:590-600
   PubMed Web of Science ®Google Scholar
• Motro M, Shemesh J. Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics. Hypertension 2001;37:1410-13
   PubMed Web of Science ®Google Scholar
• Witteman JC, Kannel WB, Wolf PA, Aortic calcified plaques and cardiovascular disease (The Framingham Study). Am J Cardiol 1990;6:1060-4
   Google Scholar
• Simon A, Gariepy J, Moyse D, Differential effects of nifedipine and co-amilozide on the porgression of early carotid wall changes. Circulation 2001;103:2949-54
   PubMed Web of Science ®Google Scholar
• Fuchs FD. Diuretics: still essential drugs for the management of hypertension. Expert Rev Cardiovasc Ther 2009;7:591-8
   PubMedGoogle Scholar
• Bakris GL, Sarafidis PA, Weir MR, for the ACCOMPLISH Trial investigators. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of randomized controlled trial. Lancet 2010;375:1173-81
   PubMed Web of Science ®Google Scholar
• De Leeuw PW, Ruilope LM, Palmer CR, Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial. Arch Intern Med 2004;164:2459-64
   PubMed Web of Science ®Google Scholar
• Voyaki SM, Staessen JA, Thijs L, Follow-up renal function in treated and untreated older patients with isolated systolic hypertension. J Hypertens 2001;19:511-19
   PubMed Web of Science ®Google Scholar
• Madkour H, Gadallah M, Riveline B, Indapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension. Am J Cardiol 1996;77:23B-5B
   PubMed Web of Science ®Google Scholar
• Siscovick DS, Raughunathan TE, Psaty BM, Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994;330:1852-7
   PubMed Web of Science ®Google Scholar
• Wing LM, Ryan P, Beilin LJ, Second Australian National Blood Pressure Study (ANBP2). Australian comparative outcome trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of Australia. Clin Expert Hypertens 1997;19:779-91
   PubMed Web of Science ®Google Scholar
• Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension 2004;43:4-9
   PubMed Web of Science ®Google Scholar
• Multiple Risk Factor Intervention Trail Research Group. Mortality after 10 ½ years for hypertensive participants in the Multiple Risk Factor Intervention Trail. Circulation 1990;82:1616-28
   PubMed Web of Science ®Google Scholar
• Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group. JAMA 1990;263:1795-801
   PubMed Web of Science ®Google Scholar
• Dorsch MP, Gillespie BW, Erickson SR, Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis. Hypertension 2011;57:689-94
   PubMed Web of Science ®Google Scholar
• Ernst M, Moser M. Use of diuretics in patients with hypertension. N Engl J Med 2009;361:2153-64
   PubMed Web of Science ®Google Scholar
• The Australian Therapeutic Trial in Mild Hypertension Management Committee. The Australian therapeutic trial in mild hypertension. Lancet 1980;1:1261-7
   PubMed Web of Science ®Google Scholar
• Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension, Results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 1967;202:1028-34
   PubMed Web of Science ®Google Scholar
• Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970;213:1143-52
   PubMed Web of Science ®Google Scholar
• Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects. Circulation 1972;45:991-1004
   PubMed Web of Science ®Google Scholar
• Robinson D, Wellington K. Indapamide sustained release: a review of its use in the treatment of hypertension. Drugs 2006;66:257-71
   PubMed Web of Science ®Google Scholar
• Bataillard A, Schiavi P, Sassard J. Pharmacological properties of indapamide: rationale for use in hypertension. Clin Pharmacokinet 1999;37:7-12
   PubMed Web of Science ®Google Scholar
• Ernst M, Moser M. Use of diuretics in patients with hypertension. N Engl J Med 2009;361:2153-64
   PubMed Web of Science ®Google Scholar
• Kurtz WT. Chlorthalidone: don't call it “Thiazide-Like” anymore. Hypertension 2010;56:335-7
   PubMed Web of Science ®Google Scholar
• Lottermoser K, Hertfelder HJ, Vetter H, Fibrinolytic function in diuretic-induced volume depletion. Am J Hypertens 2000;13:359-63
   PubMed Web of Science ®Google Scholar
• Allen JH, McKenney JM, Stratton MA, Antihypertensive effect of hydrochlorthiazide administered once or twice daily. Clin Pharm 1982;1:239-43
   PubMedGoogle Scholar
• Jamerson K, Weber MA, Bakris GL, ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008;359:2417-28
   PubMed Web of Science ®Google Scholar
• Fuchs FD. Diuretics: still essential drugs for the management of hypertension. Expert Rev Cardiovasc Ther 2009;7:591-8
   PubMedGoogle Scholar
• Barzilay JI, Davis BR, Cutler JA. Fasting glucose levels and incident diabetes mellitus in older non-diabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2006;166:2191-201
   PubMed Web of Science ®Google Scholar